The hepatic distribution kinetics of salicylic acid was determined using a
single-pass dual hepatic artery (HA) and portal vein (PV) perfused in situ
rat liver preparation. Bolus doses of [C-14]salicylic acid and of reference
markers ([H-3]-water and [C-14]-sucrose) were injected in a random order i
nto either the HA or PV and then, after an appropriate interval, into the a
lternate vessel. The hepatic outflow profile of [C-14]salicylic acid displa
yed a characteristic sharp peak followed by a slower eluting tail, whereas
sucrose and water displayed unimodal outflow profiles. The biphasic outflow
profile indicates that the hepatic distribution of salicylic acid is not i
nstantaneous but is limited by a permeability barrier. The in situ permeabi
lity surface area product for [C-14]salicylic acid was 3.35 +/- 0.26 ml/min
/g for PV and 7.45 +/- 1.50 ml/min/g for HA administration. Furthermore, th
eory dictates that hepatic uptake is influenced by both perfusion and perme
ability if effective permeability surface area product/blood flow ratio lie
s between the values of 0.06 and 7.0. Our estimates (3.0 for venous output
and 6.7 for arterial input) indicate that hepatic uptake of salicylic acid
is dependent on both perfusion and permeability. The volume terms were calc
ulated using two different methods, standard and specific. Regardless of th
e compound and method, the volume of distribution after arterial administra
tion was larger than that after venous administration. In addition, a volum
e of distribution approximately twice that of the total aqueous space (i.e,
, HA, 2.23 +/- 0.13 versus 1.10 +/- 0.07 ml/g; PV, 1.72 +/- 0.16 versus 0.6
8 +/- 0.04 ml/g) implies that salicylic acid has a significant affinity for
hepatic tissue. A similar tissue-to-perfusate partition coefficient associ
ated with HA and PV input (5.40 +/- 0.38 versus 6.48 +/- 0.56) indicates th
at affinity of salicylic acid for hepatic tissue is independent of the rout
e of input.